Formula: | C22H34N4O3 |
Molecular Weight: | 402.54 |
Rotatable Bond Donors: | 7 |
clogP: | 1.92 |
Topological Polar Surface Area: | 65.98 |
Lipinski's RO5: | MW: 402.54 HBA: 7 HBD: 0 RB: 7 LogP: 1.92 |
Rule of Three: | MW: 402.54 HBA: 7 HBD: 0 RB: 7 LogP: 1.92 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS33282 | 0.72 | EOS33282 RDKit 3D 27 29 0 0 0 0 0 0 0 0999 V2000 -1.5497 3.8989 -2.0538 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8670 3.1365 -0.8980 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.5622 1.9850 -1.3488 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7161 0.7212 -1.2431 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4287 0.0689 -2.2465 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.3017 0.3602 0.0263 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.5509 1.1912 1.1836 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7820 0.8010 1.9219 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8045 -0.2923 2.7809 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9684 -0.6100 3.4681 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0721 0.2021 3.2680 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0836 1.2797 2.4525 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.9346 1.5565 1.8036 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4669 -0.8020 0.2314 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2170 -2.0971 -0.0148 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3112 -3.2654 -0.3500 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0897 -3.1136 0.2080 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7041 -1.8684 -0.1965 N 0 0 0 0 0 0 0 0 0 0 0 0 3.0804 -1.7832 -0.1870 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7964 -2.7176 0.1659 O 0 0 0 0 0 0 0 0 0 0 0 0 3.6399 -0.4660 -0.6761 C 0 0 0 0 0 0 0 0 0 0 0 0 5.0749 -0.2845 -0.2218 C 0 0 0 0 0 0 0 0 0 0 0 0 5.8735 0.6631 -1.0928 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9948 1.6400 -1.8416 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9902 0.9378 -2.7309 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5243 -0.3961 -2.1859 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8486 -0.7457 -0.5320 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 1 0 4 5 2 0 4 6 1 0 6 7 1 0 7 8 1 0 8 9 2 0 9 10 1 0 10 11 2 0 11 12 1 0 12 13 2 0 6 14 1 0 14 15 1 0 15 16 1 0 16 17 1 0 17 18 1 0 18 19 1 0 19 20 2 0 19 21 1 0 21 22 1 0 22 23 1 0 23 24 1 0 24 25 1 0 25 26 1 0 18 27 1 0 13 8 1 0 27 14 1 0 26 21 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |